Skip to main content

Closed

PPBT: Purple Biotech Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-297.0%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage-120.2×

Current ratio1.48×

Purple Biotech Ltd.

PPBTNASDAQ Capital Market·USD·Closed

Purple Biotech Ltd.

PPBTNASDAQ·USD·Closed

$1.40

+2.19%

$1.40

+$0.03 (2.19%)

52W Range

0thpctl

Volume

0.05×avg

Mkt Cap

193318USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.05×avg

Market Cap

193318USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings